Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Nov 8, 2013 (13 years ago)

Valacyclovir Hydrochloride Tablets

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Presence of Foreign Tablets/Capsules: Potential of Pravastatin tablet fragments in bottles of Valacyclovir 1 gm Tablets.

Cause type: Particulate / foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.

What was recalled

Valacyclovir Hydrochloride Tablets, 1 g, 30 count bottle, Rx only manufactured in Israel by Teva Pharmaceuticals Ind., LTD, Jerusalem, Israel, Manufactured for Teva Pharmaceuticals USA, Sellersville, PA. NDC #0093-7259-56

Affected NDC 0093-7259-56

Compare with the code on your package — it is the most precise check available.

Drug: Acyclovir

Recalling firm
Teva Pharmaceuticals USA, Inc.
NDC code
0093-7259-56
Origin
PA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1061-2014 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Acyclovir recalls

See all
Class II · Moderate risk

Acyclovir Sodium Injection

Presence of Particulate Matter: Customer complaint for a dark red, brown and black particulate floating inside vial.

Completed Particulate / foreign matter AuroMedics Pharma LLC NDC 55150-154-10 D-0013-2023
Class III · Low risk

Acyclovir Tablets

Labeling: Incorrect or Missing Lot and/or Exp Date

Terminated Labeling / mix-up Heritage Pharmaceuticals Inc NDC 23155-227-01 D-0367-2021

Other recalls by Teva Pharmaceuticals USA, Inc.

All 2013 recalls